news

Celebrating Innovation at the Trinity Bradfield Prize Final

ip21 and demetria

On the evening of 23 February 2025, at The Bradfield Centre, we gathered to celebrate the grand finale of the Trinity Bradfield Prize, an evening dedicated to showcasing innovation and entrepreneurship.

Congratulations to this year’s prize winners:

  • Demetria Ltd: Reducing the average endometriosis diagnosis time from 9 years to just 9 minutes.
  • Powermatrix: Develops next-generation, high-performance power supplies that reduce energy loss by 30% and double power density.
  • Healthspan Biotics: Produces safe, affordable, and effective probiotic bacteria that boost brain resilience against Alzheimer’s disease.

Each finalist presented impressive high-tech solutions, highlighting the creativity and talent within the Cambridge innovation community.

We also heard from last year’s finalists, BioTryp Therapeutics and Cambridge Nucleomics, who shared updates on their journeys over the past year. Their stories were a great reminder of the value of supporting early-stage innovation and the impact it can have.

The Trinity Bradfield Prize continues to showcase the potential of Cambridge as a hub for technology, biotechnology, and entrepreneurship. We look forward to seeing what the future holds for all the finalists and their groundbreaking work.

View all news
ip21 and demetria
Left to Right: Max Ge & James Parton, Trinity Bradfield Prize Organisers; Lorna MacLean, Founder of Demetria and 2025 Trinity Bradfield Prize Winner; Sir Greg Winter, Nobel Prize Laureate; Joeeta Murphy, Cristina Penine, and Rachel Daniel from ip21